Sannova Analytical
Generated 5/10/2026
Executive Summary
Sannova Analytical is a boutique contract research organization (CRO) based in Somerset, New Jersey, founded in 2004. The company provides specialized analytical and bioanalytical services to support the development of novel and generic drugs, spanning from preclinical stages through commercialization. Emphasizing quality, speed, and flexibility, Sannova offers end-to-end CMC and bioanalytical solutions tailored to the needs of pharmaceutical and biotech clients. As a private entity in the diagnostics category, it operates in a competitive but growing CRO market, driven by increasing outsourcing of drug development activities. Its niche focus and reputation for reliability position it well for steady growth, though its small scale may limit visibility and market share compared to larger CROs.
Upcoming Catalysts (preview)
- Q3 2026New strategic partnership with a mid-sized pharma company for bioanalytical services60% success
- Q4 2026Expansion of laboratory facilities or service capabilities (e.g., high-throughput LC-MS/MS)50% success
- TBDFDA approval of a client drug that utilized Sannova's services, boosting credibility and pipeline30% success
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)